Search research articles
Contact Us
Filters
Showing results (81-90 of 89) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 89 results.
NPJ Breast Cancer
|
July 20, 2022
PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer
Elisa Agostinetto, Lieveke Ameye, Samuel Martel, et al.
Frontiers in Immunology
|
January 8, 2026
Xuebijing injection mitigates instant blood-mediated inflammatory reaction and enhances intrahepatic islet transplantation via target NF-κB pathway
Yixiang Zhan, Yingbo Wang, Boya Zhang, et al.
Cell Transplantation
|
September 16, 2025
A microporous liraglutide-releasing silk fibroin scaffold improves islet transplantation outcomes through anti-inflammatory effect
Yixiang Zhan, Xinchen Du, Yan Li, et al.
Cancer Medicine
|
December 18, 2021
What if the future of HER2-positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study
Sara Pizzamiglio, Giulia Cosentino, Chiara M Ciniselli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2021
Copy Number Aberration Analysis to Predict Response to Neoadjuvant Anti-HER2 Therapy: Results from the NeoALTTO Phase III Clinical Trial
David Venet, Mattia Rediti, Marion Maetens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 2021
Alpha-smooth Muscle Actin Expression in the Stroma Predicts Resistance to Trastuzumab in Patients with Early-stage HER2-positive Breast Cancer
Ioannis A Vathiotis, Myrto K Moutafi, Prajan Divakar, et al.
The New England Journal of Medicine
|
December 12, 2019
Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer
Dennis J Slamon, Patrick Neven, Stephen Chia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 5, 2018
Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: MONALEESA-3
Dennis J Slamon, Patrick Neven, Stephen Chia, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 12, 2023
Impact of Anti-HER2 Therapy Alone and With Weekly Paclitaxel on the Ovarian Reserve of Young Women With HER2-Positive Breast Cancer
Matteo Lambertini, Marcello Ceppi, Richard A Anderson, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 89) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 89 results.
NPJ Breast Cancer
|
July 20, 2022
PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer
Elisa Agostinetto, Lieveke Ameye, Samuel Martel, et al.
Frontiers in Immunology
|
January 8, 2026
Xuebijing injection mitigates instant blood-mediated inflammatory reaction and enhances intrahepatic islet transplantation via target NF-κB pathway
Yixiang Zhan, Yingbo Wang, Boya Zhang, et al.
Cell Transplantation
|
September 16, 2025
A microporous liraglutide-releasing silk fibroin scaffold improves islet transplantation outcomes through anti-inflammatory effect
Yixiang Zhan, Xinchen Du, Yan Li, et al.
Cancer Medicine
|
December 18, 2021
What if the future of HER2-positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study
Sara Pizzamiglio, Giulia Cosentino, Chiara M Ciniselli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2021
Copy Number Aberration Analysis to Predict Response to Neoadjuvant Anti-HER2 Therapy: Results from the NeoALTTO Phase III Clinical Trial
David Venet, Mattia Rediti, Marion Maetens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 2021
Alpha-smooth Muscle Actin Expression in the Stroma Predicts Resistance to Trastuzumab in Patients with Early-stage HER2-positive Breast Cancer
Ioannis A Vathiotis, Myrto K Moutafi, Prajan Divakar, et al.
The New England Journal of Medicine
|
December 12, 2019
Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer
Dennis J Slamon, Patrick Neven, Stephen Chia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 5, 2018
Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: MONALEESA-3
Dennis J Slamon, Patrick Neven, Stephen Chia, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 12, 2023
Impact of Anti-HER2 Therapy Alone and With Weekly Paclitaxel on the Ovarian Reserve of Young Women With HER2-Positive Breast Cancer
Matteo Lambertini, Marcello Ceppi, Richard A Anderson, et al.
Page
of 9